Women who have high blood pressure before they become pregnant may be twice as likely as those who don't to develop cardiovascular disease within a decade of giving birth, new research finds.
May 12, 2023
0
2
More than half of all preeclampsia cases that occur during weeks 37-42 of pregnancy (at-term) may be prevented with timed birth, such as a scheduled induction or Cesarean delivery, according to new research published today ...
Apr 10, 2023
0
31
Pain relievers you buy at the store may be one of the first things you reach for when you hurt yourself, have a headache or backache, or feel discomfort due to some other nagging ailment that doesn't require a visit to the ...
Mar 29, 2023
0
4
Women who have pregnancy-related health problems face an increased risk for having a stroke much earlier in life than their peers with uncomplicated pregnancies, a risk that climbs with each complicated pregnancy, new research ...
Feb 2, 2023
0
2
Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm ...
Jul 18, 2022
0
2
After decades when millions of Americans who were at risk for cardiovascular trouble were told a daily low-dose aspirin would guard against strokes and heart attacks, new guidelines issued this spring recommend that the strategy ...
Jun 22, 2022
0
10
It seemed a simple prospect—take a low-dose baby aspirin tablet once a day and reduce your risk of ever suffering a heart attack or stroke.
Apr 26, 2022
0
32
If you take a daily aspirin to help decrease your chance of a heart attack or stroke, you should check in with your health care provider. A new report indicates the over-the-counter drug may do more harm than good for some ...
Nov 16, 2021
0
8
Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific ...
Nov 15, 2021
0
3
(HealthDay)—Compared with placebo, neither aspirin nor apixaban reduces the rate of major adverse cardiovascular or pulmonary outcomes for clinically stable outpatients with symptomatic COVID-19, according to a study published ...
Oct 18, 2021
0
16
